Then, the upregulated LDHB could activate glycolysis and decrease GEM sensitivity in pancreatic cancer, and the increased glutamine synthetase and decreased glutaminase could further increase the level of intracellular glutamine, which is indispensable for mTOR activation. Here, GLS is linked to pancreatic neoplasm.